Request that the FDA determine whether DDAVP (desmopressin acetate) Nasal Spray, 0.01 mg/Spray (Needs No Refrigeration), Product No. 003 approved under New Drug Application (NDA) number 017922, held by Ferring Pharmaceuticals, Inc., has been voluntarily withdrawn for reasons of safety or effectiveness. | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-8286

Request that the FDA determine whether DDAVP (desmopressin acetate) Nasal Spray, 0.01 mg/Spray (Needs No Refrigeration), Product No. 003 approved under New Drug Application (NDA) number 017922, held by Ferring Pharmaceuticals, Inc., has been voluntarily withdrawn for reasons of safety or effectiveness.

Documents

Comments

Description

OPEN

Key Dates

Comment Period OpensJul 28, 2026

Documents

Type	Title	Posted	Comments	Status
Other	Acknowledgment Letter from FDA DMB to Hyman, Phelps & McNamara, P.C.	Jul 28, 2026	--

Keywords

CDER

Hyman, Phelps & McNamara, P.C.

determine whether DDAVP

(desmopressin acetate) Nasal Spray

0.01 mg/Spray (Needs No Refrigeration),

Product No. 003 approved under

New Drug Application (NDA)

number 017922, held by

Data from Regulations.gov